These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Drug patent plan gets mixed reviews. Butler D Nature; 2009 Feb; 457(7233):1064. PubMed ID: 19256077 [No Abstract] [Full Text] [Related]
5. Redesigner drugs. Dove A Nat Biotechnol; 2004 Aug; 22(8):953-7. PubMed ID: 15286643 [TBL] [Abstract][Full Text] [Related]
6. Effects of patent abolition on the drug industry. SMITH A Appl Ther; 1963 May; 5():433-7. PubMed ID: 13993111 [No Abstract] [Full Text] [Related]
7. Sales from licensed and acquired products to increase by 2013. Goodman M Nat Rev Drug Discov; 2009 Jun; 8(6):443. PubMed ID: 19483704 [No Abstract] [Full Text] [Related]
9. Are rich nations up for drug reform? Check E Nature; 2006 May; 441(7090):135. PubMed ID: 16688137 [No Abstract] [Full Text] [Related]
10. Patent watch: Drug patenting in India: looking back and looking forward. Sampat BN; Shadlen KC Nat Rev Drug Discov; 2015 Aug; 14(8):519-20. PubMed ID: 26184492 [No Abstract] [Full Text] [Related]
11. Enforcing pharmaceutical and biotech patent rights in China. Zhang YP; Deng MM Nat Biotechnol; 2008 Nov; 26(11):1235-40. PubMed ID: 18997760 [No Abstract] [Full Text] [Related]
12. Patent highlights October-November 2017. Mucke HA Pharm Pat Anal; 2018 Mar; 7(2):73-81. PubMed ID: 29417883 [TBL] [Abstract][Full Text] [Related]
13. The use of generic or patent medicines in the Netherlands. Gebhardt DO J Med Ethics; 2005 Jul; 31(7):409. PubMed ID: 15994361 [No Abstract] [Full Text] [Related]
14. A day late and a few million dollars short. Goldenson D Nat Biotechnol; 2009 Jun; 27(6):538-41. PubMed ID: 19513055 [TBL] [Abstract][Full Text] [Related]
15. Kinase patent space visualization using chemical replacements. Southall NT; Ajay J Med Chem; 2006 Mar; 49(6):2103-9. PubMed ID: 16539399 [TBL] [Abstract][Full Text] [Related]
16. Pharmaceutical Portfolio & Product Life Cycle Management--SMi's fourth annual conference. 29-30 June 2009, London, UK. Beecher N IDrugs; 2009 Sep; 12(9):558-60. PubMed ID: 19697274 [No Abstract] [Full Text] [Related]
17. Pills, patents, and power: state creation of gray markets as a limit on patent rights. Ghosh S Fla J Int Law; 2002; 14(2):217-60. PubMed ID: 16526138 [No Abstract] [Full Text] [Related]